TELEPHARMASITE.COMYour reliable supplier of generic medications
$0.00 (0 items)Checkout

Categories list

Social bookmarks:

Our billing is certified by:

Secure shopping certificates

Special Offer!

Anticonvulsants

Search by letter:

ABCDEFGHIJKLMNOPQRSTUVWXYZ
 
 
 
Depakote $0.75
Per Pill
DepakoteDivalproex 125/250/500mg
Buy now!
Dilantin $0.82
Per Pill
DilantinPhenytoin 100mg
Buy now!
Lamictal $1.50
Per Pill
LamictalLamotrigine 25/50/100mg
Buy now!
Lamictal Dispersible $1.19
Per Pill
Lamictal DispersibleLamotrigine 25/50/100mg
Buy now!
Mysoline $1.11
Per Pill
MysolinePrimidone 250mg
Buy now!
Neurontin $1.14
Per Pill
NeurontinGabapentin 300/400mg
Buy now!
Tegretol $0.78
Per Pill
TegretolCarbamazepine 100/200/400mg
Buy now!
Topamax $1.00
Per Pill
TopamaxTopiramate 25/50/100mg
Buy now!
Trileptal $0.92
Per Pill
TrileptalOxcarbazepine 150/300/600mg
Buy now!
 
quicksearch
quicksearch

Well, I must apologize - I thought surely you were scamming me. But, all of a sudden, my mailbox overflows. I received one order on Thursday, 8 June, and then another on Saturday, 10 June. Almost 1 month from our first effort, but the postal service must be the culprits. With this double supply, you are now going to have to send me a couple of women, so the meds don't go to waste. How can we make this right? What would you like me to do? Thanks. I hope only good karma comes to you. - Curt


Moneyback Guarantee
bookmark Bookmark this site

Latest News

  • Medication can cause weight gain - Health24.com

    Health24.

  • From the analyst's couch: The neuropathic pain market - Nature.com

    Nature.

  • Epilepsy support group meets Jan. 21 - Killeen Daily Herald

    Epilepsy support group meets Jan.

  • Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended ... - MarketWatch (press release)

    Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended .

  • Common Pain Options of Little Help for RA Patients - Everyday Health

    Common Pain Options of Little Help for RA PatientsEveryday HealthThe second review, also by Richards' group, summarized the evidence for pain control with neuromodulating agents, such as anticonvulsants, a treatment approach that has become increasingly common in various pain syndromes.